The objective of this study was to identify frequency and predictors of gaps in care in a longitudinal cohort of HIV-infected patients in urban New England. We conducted a retrospective cohort study in Providence, RI, of 581 newly diagnosed HIV patients >18 entering into care from 2004 to 2010, and followed their care through the end of 2011. The outcome of interest was gaps in care, defined as an interruption of medical care for >6 months. Time to the first gap was characterized using Kaplan-Meier (KM) curves. Anderson-Gill proportional hazards (AGPH) model was used to identify the risk factors of recurrent gaps in care. During the study period, 368 patients (63%) experienced at least 1 gap in care, 178 (30%) had ≥2 gaps, 84 (14.5%) had ≥3 gaps, and 21 (3.6%) died; 77% of the gaps were followed by a re-linkage with care The KM curves estimate that one-quarter of patients (95% CI = 22-29%) would experience ≥1 gap in care by Year 1; nearly one-half (CI = 45-54%) by Year 2; and 90% (CI = 93-96%) by Year 8. A prior gap was a strong predictor (HR = 2.36; CI = 2.16-2.58) of subsequent gaps; other predictors included age <25 (HR = 1.29; CI = 1.04-1.60), and no prescription of ART in first year of care (HR = 1.23; CI = 1.01-1.50). The results of this study suggest that a significant proportion of newly diagnosed HIV-infected patients will experience multiple gaps in care and yet re-engagement is possible. Interventions should focus on both prevention of gaps as well as re-engaging those lost to follow-up.
Background
Over the past 15 years, potent, well-tolerated antiretroviral therapy (ART) has transformed HIV into a manageable chronic illness in the USA (Bhaskaran et al., 2008) . As with other chronic diseases, favorable outcomes are dependent on adequate access to and consistent engagement with medical care (Swendeman, Ingram, & Rotheram-Borus, 2009 ). HIV-infected individuals who are poorly adherent to HIV medical care are less likely to receive ART, have lower adherence to ART, increased virological failure, and poorer health outcomes (Giordano et al., 2007; Mugavero et al., 2009) . Maintaining continuity in HIV care is a significant public health issue as adherence to ART markedly decreases HIV transmission (Cohen et al., 2011) . The US Centers for Disease Control and Prevention (CDC) estimates that almost half of all HIV-infected individuals in the USA are not in regular care, and less than one-third have an undetectable viral load ("Vital signs: HIV prevention through care and treatment -United States," 2011). The significance of this issue is highlighted by the emphasis placed on maximizing retention in care in the US National HIV/ AIDS Strategy and by new guidelines from the Department of Health and Human Services advocating universal access to ART as part of a treatment as prevention approach to impacting the HIV epidemic (DHHS, 2013) .
Improving retention with HIV care requires a detailed understanding of the longitudinal course of engagement with outpatient care. The transition process from HIV diagnosis to retention comprises several steps from diagnosis to full engagement with HIV treatment, and the treatment cascade is not unidirectional (Malitz & Eldred, 2007) . Thus, identifying those most at risk for loss to follow-up (LTFU), and importantly, multiple gaps in care, can considerably impact the development of interventions at clinic and community levels.
Studies conducted in a wide variety of settings in the USA have identified individual predictors of poor retention in HIV care including younger age, minority status, poverty, substance use, and incarceration (Catz, McClure, Jones, & Brantley, 1999; Giordano et al., 2003; Kerr et al., 2005; Olatosi, Probst, Stoskopf, Martin, & Duffus, 2009 ). Yet, most of these studies were based on cross-sectional or fixed panel (e.g., every 6 months) data and did not account for the fact that retention is a dynamic process and clinical visits for care are irregular in time. A better understanding of these factors and their impact on the time-dependent risk of disengagement in HIV care is necessary. We therefore studied engagement with care, gaps in care, and re-engagement over an 8-year period at the care site where the majority of patients in Rhode Island receive their HIV care. An advantage of this care setting is that there is less geographic mobility in this population than in others in the USA (U.S. Census Bureau, 2011). Using retrospective data from a center database, we want to address two scientific questions: (1) What were the rates of having gap(s) in HIV care and re-engagements? and (2) What factors predicted gaps in HIV care?
Methods

Participants
The Miriam Hospital Immunology Center is an urban clinic that provides care for 1600 HIV-infected patients in Rhode Island. In this analysis, we considered all patients presenting for care within 1 year of their HIV diagnosis and registered into the Immunology Center Database (ICDB) between 1 January 2004 and 31 December 2010 (N = 581), and included their follow-up visit data until 31 December 2011. The ICDB is a relational database created in 2003 on a Structured Query Language server maintained by the Lifespan/Miriam Hospital Information Systems department. It contains socio-demographics, detailed clinic visits, and medical data. All study procedures were approved by The Miriam Hospital Institutional Review Board.
Variables
Multiple measures of retention in HIV care have been proposed including missed visits, gaps in care, visit constancy, and the HRSA HIV/AIDS Bureau annual measure (at least two kept visits separated by ≥90 days), with no single measure outperforming others in relationship to clinical outcomes . Given our primary interest in identifying individuals with inconsistent engagement with longitudinal HIV care, we focused our analysis on characterizing patients who would experience at least one gap in care, defined as an interruption of HIV medical care for >6 months, and contextualizing the factors that may inform those gaps.
Covariates included gender, age, race, ethnicity, education level, birth origin (US versus other), clinic registration year, HIV risk category, CD4+ T cell count, and AIDS diagnosis at presentation to care, prescription of ART within 1 year of care entry, and history of: mental illness, substance use, incarceration, and housing instability. Age, race, education, registration date, HIV risk category, and CD4 count were coded as categorical variables; all other variables were coded as binary variables. Gender, age, race, ethnicity, education level, birth origin, and history of mental illness, substance use, and housing were based on a self-report at initial intake.
The primary outcome is time to recurrent gaps in care. HIV plasma viral load (PVL) and experience of prior gap(s) in HIV medical care were included in the regression analyses as time-dependent variables.
Analyses
The characteristics of study population were summarized by tabulating their baseline (at registration) demographic, clinical, and behavioral covariates.
Time to the primary endpoint was measured from registration date to the occurrence(s) of having a gap (>6 months) between medical visits. The primary endpoint can be right-censored (i.e., only known to occur later than the last observation time) due to reasons such as "moving out of the state", "transfer to other HIV clinic", "incarceration", or the end of study period (31 December 2011). Death is first considered as a censoring event, not as a primary endpoint. We also tested models in which death was considered as one of the primary endpoints, i.e., as a terminal LTFU. This approach reflects that both gaps and deaths are undesired endpoints, and of clinical interest.
In order to account for the variable length of follow-up of patients, we used time-to-event (survival) analysis methods. Distribution of time to the first gap was graphically summarized using the Kaplan-Meier (KM) survival curves. The Anderson-Gill proportional hazards (AGPH) model was used to quantify the effect of risk factors on retention in HIV care (Andersen & Gill, 1982) . Univariable AGPH regressions were used to examine the predictive value of each factor individually. Important factors (p-value < 0.10 in univariable analyses) were then included in a multivariable AGPH model.
Early engagement in HIV care within 1 year of diagnosis has been shown to be predictive of clinical outcomes and is a particular focus of nationwide outreach campaigns (Mugavero, Amico, et al., 2012; Tripathi, Youmans, Gibson, & Duffus, 2011) . As an exploratory analysis, we further conducted a cross-sectional analysis restricting the follow-up period to the first year of entry to care (Table 3) . We compared the baseline demographic and health characteristics between those patients who had a gap in care in their first year and those who did not, using Pearson's chi-square test or Fisher's exact test (if any cell of the contingency table has a count of ≤5; Agresti, 2002) .
A level of significance of < 0.05 was used throughout this paper. All analyses were carried out using Stata (Version 12.1, College Station, TX 77845).
Results
Participant characteristics
Demographic and health characteristics of the 581 individuals are summarized in Table 1 . The study samples are comparable to the overall clinic population at The Miriam Hospital Immunology Center (Lifespan/Tufts/Brown Center for AIDS Research, 2013). The majority were male (71%), white (62%), non-Hispanic (76%), US born (58%), and had a high school or higher education (64%). The median age at entry to care was 38 years (interquartile range (IQR) = 35-45), 46% were classified as AIDS at presentation, with 60% of all patients prescribed ART during the first year of entry into care. Risk factors for HIV included men who have sex with men (MSM, 47%), unprotected heterosexual sex (47%), and intravenous drug use (4%).
In this cohort, 368 patients (63%) experienced at least 1 gap of >6 months in care, 178 (30%) had ≥2 gaps, 84 (14.5%) had ≥3 gaps in care, and 21 (3.6%) died over their follow-up period ( Table 2) . About 77% of the gaps were followed by a subsequent visit in the clinic while the rest (23%) were considered completely LTFU. Among those experiencing at least one gap, the length of gap had a median of 325 days and an IQR of 231~366 days. Of note, these estimates do not account for differential follow-up times of the study population.
Analyses of gaps in care
The KM curve (Figure 1 , left panel) looking at time to the first gap estimates that of all patients, 24% (95% CI = 20-27%) experienced the first gap (in other words, at least one gap) in the first year of care; nearly one-half (48%, 95% CI = 44-53%) by Year 2; and 90% (95% CI = 83-96%) by their eighth year of follow-up, if death is not counted as a gap. When including death as a primary endpoint of interest, the curve (Figure 1 , right panel) is almost identical.
Treating death as a censoring event, the univariable AGPH regression analyses (Table 3 , left panel) show that age <35 (HR = 1.48-2.29), non-Hispanic ethnicity (HR = 1.39; CI = 1.09-1.767), non-AIDS at presentation (HR = 1.47; CI = 1.23-1.76), substance use (HR = 1.23; CI = 1.02-1.47), homelessness (HR = 1.29; CI = 1.05-1.58), history of incarceration (HR = 1.62; CI = 1.18-2.23), (Table 3 , right panel) shows that age <25 (HR = 1.35; CI = 1.09-1.68), not prescribed ART during the first year of care (HR = 1.21; CI = 1.01-1.58), and a prior gap (HR = 2.41; CI = 2.20-2.64) were independently associated with a higher risk of experiencing gaps in care. Analyses using death as an outcome were similar (not shown).
Given the relatively high rate of gaps in care in Year 1, we performed a cross-sectional analysis of the firstyear follow-up (Table 4 ). Younger age (<35), non-AIDS presentation, ever-smoking, never having psychiatric illness, high CD4 count, and not on ART in the first year were associated with having a gap in care in the first year. The comparisons were not adjusted for death, incarcerations, or transfer of care.
Discussion
This study has two main findings. First, gaps in care are frequent among HIV-infected patients. In our study period, 63% of patients experienced at least one gap in care and had they all been followed up for 8 years, it is estimated that 90% of patients would experience one or more gaps. Second, in multivariable models younger age, not being on ART in the first year of follow-up, and previous gaps were the only predictors of gaps in care.
Our findings on rates of gaps in care contrasts with a recent study evaluating longitudinal retention patterns in patients entering into the North American AIDS Cohort Collaboration (NA-ACCORD) from 2000 to 2008, where 75% of individuals were consistently retained in HIV care (Rebeiro et al., 2013) . However, NA-ACCORD only included individuals who completed at least two clinical visits in the prior 12 months; thus, potentially excluding individuals who disengage with care within the first year. A strength of our study is that we included new HIV diagnoses at the time of entry into medical care from 2004 to 2010. Approximately 24% of our patients experienced their first gap in care within the first year, and those who experienced one gap were more likely to experience subsequent gaps. Early engagement in HIV care within 1 year of diagnosis has been shown to be predictive of clinical outcomes and is a particular focus of nationwide outreach campaigns (Mugavero, Amico, et al., 2012; Tripathi et al., 2011) . Also, NA-ACCORD defined LTFU as no laboratory data in ≥12 months, whereas we used the definition of no clinic visit >6 months. Laboratory results may not accurately reflect actual clinic visits (Mugavero, Davila, Nevin, & Giordano, 2010) . This may explain the lower rates of continuous engagement in our study compared to the NA-ACCORD study.
The survival analysis evaluating time to first gap in care (Figure 1 ) displays a steep initial drop within the first 2 years of care that continues to decline over the entire follow-up period. This pattern suggests that over time, LTFU is virtually certain in the longitudinal care of HIVinfected patients. However, patients may return to care after LTFU. Our data show that re-engagement is possible with the majority (77%) of gaps followed by a subsequent re-linkage to care, even with a median gap of almost 1 year. A recent study in New York testing an active public health outreach effort for patients LTFU for >9 months successfully re-linked over one-half of all patients (Udeagu, Webster, Bocour, Michel, & Shepard, 2013) . Consequently, the development of retention interventions should focus both on preventing LTFU in the first place, but also on re-engaging patients once it occurs.
Our multivariable models indicated that younger age, lack of prescription of ART in Year 1, and a history of prior gap are predictors of gaps in care; younger age and lack of ART prescription were also associated with a gap in the first year of care. Younger age has been associated with poor retention in HIV care in prior studies, likely reflective of more recent, asymptomatic infections (Catz et al., 1999; Olatosi et al., 2009) . In this cohort, 40% of patients were not prescribed ART in the first year. While this finding seems to support current recommendations to offer ART to all HIV-infected individuals, this may reflect a selection bias in that individuals who stayed in care in their first year were more likely to have the opportunity to be prescribed ART. Having experienced a gap in care was also highly predictive of subsequent gaps in care both on univariable and on multivariable analyses. In another longitudinal cohort of >17,000 HIVinfected patients in the USA, 59% of patients engaged in HIV care had a >6 month gap between outpatient visits, with 28% having one or more gaps >12 months (Yehia et al., 2012) . Considering that almost one in four patients in this cohort experienced a gap within their first year of entry into care, focusing resources on the first year of entry in care could potentially impact future engagement AIDS Care 683 and thus longitudinal outcomes in the highest risk patients. Moreover, individuals re-engaging after experiencing gaps in care will likely benefit from enhanced services that can address their individual reasons for lack of follow-up in order to prevent these gaps from occurring again. Certain characteristics associated with inconsistent engagement in other studies, including prior incarceration, homelessness, substance use, and higher CD4 counts while significant on the univariable model were not significant in the multivariable model. The incarceration rate in our cohort is low which may explain this discrepancy on the multivariable model. All three variables may also be underreported as they are selfreported measures collected at the time of entry to care and are not necessarily reflective of ongoing or developing problems with these issues. Collinearity between the variables of homelessness and incarceration, and incarceration and substance use may also explain this finding. Likewise, CD4 counts were strongly associated with ART status in the first year of care.
Our study also did not find an association between inconsistent engagement in HIV care with having a detectable HIV PVL as described in other studies (Mugavero, Amico, et al., 2012) . This may be explained by the fact that patients who were non-adherent to treatment were also not having lab work performed.
Our finding of few predictors of gaps in care may indicate that particular subgroups are not more likely to be lost to care in our clinic, suggesting fewer disparities in care at the Immunology Center. It also suggests that quality improvement approaches should target the broad population of patients entering care rather than developing interventions targeting subgroups. The finding that the risk of gaps in care this cohort is high (63% experienced at least one gap in care) also supports this approach.
There are several limitations to this study. As mentioned previously, certain variables such as incarceration, homelessness, and substance use are based on self-report at the time of entry in care; a better assessment of the ongoing role of this factors in longitudinal retention would more accurately describe their impact. Additionally, this is a single site study with a limited sample size (N = 581). Both the population and local context that impact retention in care may not be generalizable to other populations. However, forming meaningful, cost-effective interventions addressing an issue as complex as retention requires acknowledging the influence of multiple individual and local environmental factors; a detailed synthesis of these determinants is a critical component of this process. As this study included data from a single clinic, we are assuming that patients were not receiving HIV care elsewhere. It is possible that patients may switch to a different provider in the same locality, move elsewhere even for a temporary period where they are engaged with care, or become incarcerated or institutionalized but continue to have access to HIV medication and treatment. In this case, access to laboratory results reported to a central entity such as a state health department could supplement available clinical data as a proxy for out-of-network care in analysis purposes, with the knowledge that laboratory results may not necessarily equate with clinical care.
While gaps in care were not associated with mortality, investigation of this association was limited due to the overall low number of deaths in this cohort. Additionally, our data quantifying frequency of gaps in care (Table 2) do not account for differential follow-up times of the study population, and hence provide underestimates of actual gap rates.
To address the HIV epidemic in the country, the 2010 US National HIV/AIDS Strategy proposed as one of its key measures establishing "a seamless system to immediately link people to continuous and coordinated quality care when they are diagnosed with HIV." Our study found that gaps in care are frequent and likely over the course of time, and yet re-engagement is also possible. Therefore, equal emphasis must be placed on the prevention of initial gaps in care as well as on reengaging those LTFU. Few predictors of gaps in care in a setting with high risk of gaps suggests quality improvement interventions may need to be broadly applicable rather than focusing on particular subgroups. Clinic-level evaluations to understand the elements contributing to inconsistent engagement with care are necessary step prior to the implementation of interventions to achieve this goal.
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